There are 2789 resources available
No
Presenter: Michael Untch
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Sibylle Loibl
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast
Q&A
Presenter: Sibylle Loibl
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast
Live welcome and introduction
Presenter: Alicia Morgans
Session: Bayer - Taking action in nmCRPC: Cases in the clinic
Resources:
Webcast
Living with nmCRPC: A patient’s perspective
Presenter: Alicia Morgans
Session: Bayer - Taking action in nmCRPC: Cases in the clinic
Resources:
Webcast
Meeting patient needs: Understanding nmCRPC treatment options
Presenter: Bertrand Tombal
Session: Bayer - Taking action in nmCRPC: Cases in the clinic
Resources:
Webcast
Case 1: Treat early for extended survival
Presenter: Daniel George
Session: Bayer - Taking action in nmCRPC: Cases in the clinic
Resources:
Webcast
Case 1: Live discussion
Presenter: Alicia Morgans
Session: Bayer - Taking action in nmCRPC: Cases in the clinic
Resources:
Webcast
Introduction
Presenter: Joyce O'Shaughnessy
Session: Medscape - A Stepwise Approach To Managing HR+/HER2- Early Breast Cancer: From Risk Assessment To Risk Management
Resources:
Webcast
First step: identifying patients at high risk of recurrence
Presenter: Joyce O'Shaughnessy
Session: Medscape - A Stepwise Approach To Managing HR+/HER2- Early Breast Cancer: From Risk Assessment To Risk Management
Resources:
Webcast